본문 바로가기
KERD
논문KCI 등재

Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: Insulin resistance (IR) has an important role in the development of non-alcoholic steatohepatitis (NASH). We aimed to analyze the association between liver histopathology and IR in pediatric patients with NASH. Materials and Methods: In 24 children with non-alcoholic fatty liver disease (NAFLD), we investigated whether the hepatic pathologiccharacteristics have relations with following three biochemical indices; IR index including homeostasis model assessment of IR (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), and insulin sensitivity indices-free fatty acid (ISI-FFA). Results: Among 24 patients, 16 (66.6%) had a high NAFLD activity score (NAS), which is diagnostic of NASH. Higher serum triglyceridelevel was significantly correlated with a high NAS. Higher steatosis grades were significantly associated with low insulin sensitivity (p=0.023). In addition, severe lobular inflammation was associated with higher IR: HOMA-IR (p=0.014) and QUICKI (p=0.023). Severe fibrosis correlated with low insulin sensitivity and high IR indexes: ISI-FFA (p=0.049), HOMA-IR (p=0.028), and QUICKI (p=0.007). Conclusion: Patients with high IR had more severe lobular inflammation and hepatic fibrosis. Analyses of biochemical and endocrineparameters can be applied to determine the severity of the hepatic pathologic status in patients with NASH, especially in children who cannot undergo a liver biopsy.

Abstract

Purpose: Insulin resistance (IR) has an important role in the development of non-alcoholic steatohepatitis (NASH). We aimed to analyze the association between liver histopathology and IR in pediatric patients with NASH. Materials and Methods: In 24 children with non-alcoholic fatty liver disease (NAFLD), we investigated whether the hepatic pathologiccharacteristics have relations with following three biochemical indices; IR index including homeostasis model assessment of IR (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), and insulin sensitivity indices-free fatty acid (ISI-FFA). Results: Among 24 patients, 16 (66.6%) had a high NAFLD activity score (NAS), which is diagnostic of NASH. Higher serum triglyceridelevel was significantly correlated with a high NAS. Higher steatosis grades were significantly associated with low insulin sensitivity (p=0.023). In addition, severe lobular inflammation was associated with higher IR: HOMA-IR (p=0.014) and QUICKI (p=0.023). Severe fibrosis correlated with low insulin sensitivity and high IR indexes: ISI-FFA (p=0.049), HOMA-IR (p=0.028), and QUICKI (p=0.007). Conclusion: Patients with high IR had more severe lobular inflammation and hepatic fibrosis. Analyses of biochemical and endocrineparameters can be applied to determine the severity of the hepatic pathologic status in patients with NASH, especially in children who cannot undergo a liver biopsy.

참고문헌 (42)

  1. 오경원, "한국 소아청소년의 비만 유병률 추이: 1997년과 2005년 비교", Korean Journal of Pediatrics, 51(9), pp.950~955 (2008), 대한소아과학회
  2. Geoffrey C. Farrell, "NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications", Gut and Liver, 6(2), pp.149~171 (2012), 거트앤리버 발행위원회
  3. Watanabe S, "Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease", nonalcoholic steatohepatitis, 2015, pp.50, 364~377
  4. Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
  5. Brunt EM, "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions", Am J Gastroenterol, 94, pp.2467~2474 (1999)
  6. 고재성, "비알코올성 지방간질환", 대한소화기학회지, 56(1), pp.6~14 (2010), 대한소화기학회
  7. 서정완, "소아 비알코올 지방간질환의 최신지견", Pediatric Gastroenterology, Hepatology & Nutrition, 14(3), pp.209~221 (2011), 대한소아소화기영양학회
  8. Venkatesan P, "Surrogate measures of insulin sensitivity when compared to euglycemic hyperinsulinemic clamp studies in Asian Indian men without diabetes", J Diabetes Complications, 30, pp.287~291 (2016)
  9. Katz A, "Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans", J Clin Endocrinol Metab, 85, pp.2402~2410 (2000)
  10. Matthews DR, "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28, pp.412~419 (1985)
  11. Belfiore F, "Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels", Mol Genet Metab, 63, pp.134~141 (1998)
  12. Arata M, "Nonalcoholic steatohepatitis and insulin resistance in children", World J Diabetes, 5, pp.917~923 (2014)
  13. Hyun Chin Cho, "Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population", Gut and Liver, 10(1), pp.117~125 (2016), 거트앤리버 발행위원회
  14. Calcaterra V, "Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity", Clin Endocrinol (Oxf), 68, pp.868~872 (2008)
  15. Yi KH, "Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: a population-based study", Diabetes Res Clin Pract, 103, pp.106~113 (2014)
  16. 류재홍, "The Risk for Insulin Resistance according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men", Journal of Korean Medical Science, 31(11), pp.1761~1767 (2016), 대한의학회
  17. Cole TJ, "Establishing a standard definition for child overweight and obesity worldwide: international survey", BMJ, 320, pp.1240~1243 (2000)
  18. Valerio G, "Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy", Nutr Metab Cardiovasc Dis, 16, pp.279~284 (2006)
  19. Reinehr T, "Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids", Metabolism, 54, pp.397~402 (2005)
  20. Brown RJ, "Estimation of insulin sensitivity in children:methods, measures and controversies", Pediatr Diabetes, 15, pp.151~161 (2014)
  21. Hrebícek J, "Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention", J Clin Endocrinol Metab, 87, pp.144~147 (2002)
  22. Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
  23. Larter CZ, "A fresh look at NASH pathogenesis. Part 1: the metabolic movers", J Gastroenterol Hepatol, 25, pp.672~690 (2010)
  24. Chitturi S, "NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome", Hepatology, 35, pp.373~379 (2002)
  25. Marchesini G, "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", Hepatology, 37, pp.917~923 (2003)
  26. Wong RJ, "Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States", Gastroenterology, 148, pp.547~555 (2015)
  27. Wang X, "Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 12, pp.394~402 (2014)
  28. Alkhouri N, "Liver transplantation for nonalcoholic steatohepatitis in young patients", Transpl Int, 29, pp.418~424 (2016)
  29. Min-Su Oh, "Associations among the Degree of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, Degree of Obesity in Children, and Parental Obesity", Pediatric Gastroenterology, Hepatology & Nutrition, 19(3), pp.199~206 (2016), 대한소아소화기영양학회
  30. Leclercq IA, "Leptin is essential for the hepatic fibrogenic response to chronic liver injury", J Hepatol, 37, pp.206~213 (2002)
  31. 지수정, "소아 비알코올성 지방간질환의 병리 소견과 임상적, 영상학적소견의 상관성", 대한소화기학회지, 57(3), pp.158~165 (2011), 대한소화기학회
  32. Matteoni CA, "Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity", Gastroenterology, 116, pp.1413~1419 (1999)
  33. Bugianesi E, "Expanding the natural history of nonalcoholic steatohepatitis:from cryptogenic cirrhosis to hepatocellular carcinoma", Gastroenterology, 123, pp.134~140 (2002)
  34. Singh S, "Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis:a systematic review and meta-analysis of paired-biopsy studies", Clin Gastroenterol Hepatol, 13, pp.643~654 (2015)
  35. Patton HM, "Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis", Gastroenterology, 135, pp.1961~1971 (2008)
  36. Rössner SM, "HOMAIR and QUICKI: decide on a general standard instead of making further comparisons", Acta Paediatr, 99, pp.1735~1740 (2010)
  37. Pirgon Ö, "Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease", J Clin Res Pediatr Endocrinol, 5, pp.33~39 (2013)
  38. Carter-Kent C, "Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study", Hepatology, 50, pp.1113~1120 (2009)
  39. Takahashi Y, "Histopathological characteristics of non-alcoholic fatty liver disease in children: comparison with adult cases", Hepatol Res, 41, pp.1066~1074 (2011)
  40. Day CP, "Steatohepatitis: a tale of two “hits”?", Gastroenterology, 114, pp.842~845 (1998)
  41. Cali AM, "Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?", Hepatology, 49, pp.1896~1903 (2009)
  42. 한광협, "The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter", Yonsei Medical Journal, 57(4), pp.885~892 (2016), 연세대학교의과대학[DOI]

이 간행물의 다른 논문 (19건)